Abstract
A novel horseradish peroxidase-encapsulated silica nanoparticle (SNP) was generated in this study under relatively mild conditions. The generated enzyme-encapsulated SNP were relatively uniform in size (average 70 ± 14.3 nm), monodispersed, and spherical, as characterized by transmission electron microscopy and scanning electron microscopy. The horseradish peroxidase encapsulated in silica nanoparticle exhibits biological properties, such as a pH-dependent activity profile and k m value, similar to that of free enzymes. Furthermore, enzyme-encapsulated SNP exhibited good operational stability for the repetitive usage with a relative standard deviation of 5.1 % (n = 10) and a high stability for long term storage (>60 days) at 4 °C. The feasibility of using enzyme-encapsulated SNP in prodrug cancer therapy was also demonstrated by its capability to convert the prodrug indole-3-acetic acid into cytotoxic peroxyl radicals and trigger the death of tumor cells. These results indicate that the developed enzyme-encapsulated SNP has potential in the applications of prodrug cancer therapy.
Similar content being viewed by others
References
Ahmad S, Tester RF, Corbett A, Karkalas J (2006) Dextran and 5-aminosalicylic acid (5-ASA) conjugates: synthesis, characterisation and enzymic hydrolysis. Carbohydr Res 341:2694–2701
Alexis F, Rhee JW, Richie JP, Radovic-Moreno AF, Langer R, Farokhzad OC (2008) New frontiers in nanotechnology for cancer treatment. Urol Oncol: Semin Ori Invest 26:74–85
Amine A, Mohammadi H, Bourais I, Palleschi G (2006) Enzyme inhibition-based biosensors for food safety and environmental monitoring. Biosens Bioelectron 21:1405–1423
Bae KH, Chung HJ, Park TG (2011) Nanomaterials for cancer therapy and imaging. Mol Cell 31:295–302
Bagshawe K (1990) Antibody-directed enzyme/prodrug therapy (ADEPT). Biochem Soc Trans 18:750–752
Baroli B, Ennas MG, Loffredo F, Isola M, Pinna R, López-Quintela MA (2007) Penetration of metallic nanoparticles in human full-thickness skin. J Invest Dermatol 127:1701–1712
Bauduin P, Nohmie F, Touraud D, Neueder R, Kunz W, Ninham BW (2006) Hofmeister specific-ion effects on enzyme activity and buffer pH: horseradish peroxidase in citrate buffer. J Mol Liq 123:14–19
Candeias LP, Folkes LK, Porssa M, Parrick J, Wardman P (1996) Rates of reaction of indoleacetic acids with horseradish peroxidase compound I and their dependence on the redox potentials. Biochemistry 35:102–108
Connors TA (1995) The choice of prodrugs for gene directed enzyme prodrug therapy of cancer. Gene Ther 2:702–709
Connors TA, Knox RJ (1995) Prodrugs in cancer chemotherapy. Stem Cells 13:501–511
Farokhzad OC, Langer R (2006) Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev 58:1456–1459
Ferrari M (2005) Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5:161–171
Fuchs S, Kapp T, Otto H, Schoneberg T, Franke P, Gust R, Schlüter AD (2004) A set of surface-modified dendrimers with potential application as drug delivery vehicles: synthesis, in vitro cytotoxicity, and intracellular localization. Chemistry 10:1167–1192
Gallati H (1979) Horseradish peroxidase: a study of the kinetics and the determination of optimal reaction conditions, using hydrogen peroxide and 2,2′-azinobis 3-ethylbenzthiazoline-6-sulfonic acid (ABTS) as substrates. J Clin Chem Clin Biochem 17:1–7
Gazarian IG, Lagrimini LM, Mellon FA, Naldrett MJ, Ashby GA, Thorneley RN (1998) Identification of skatolyl hydroperoxide and its role in the peroxidase-catalysed oxidation of indol-3-yl acetic acid. Biochem J 333:223–232
Gesson JP, Jacquesy JC, Mondon M, Petit P, Renoux B, Andrianomenjanahary S, Van Dufat-Trinh H, Koch M et al (1994) Prodrugs of anthracyclines for chemotherapy via enzyme-monoclonal antibody conjugates. Anticancer Drug Des 9:409–423
Gopin A, Ebner S, Attali B, Shabat D (2006) Enzymatic activation of second-generation dendritic prodrugs: conjugation of self-immolative dendrimers with poly(ethylene glycol) via click chemistry. Bioconj Chem 17:1432–1440
Guthaus E, Burgle M, Schmiedeberg N, Hocke S, Eickler A, Kramer MD, Sweep CG, Magdolen V et al (2002) uPA-silica-particles (SP-uPA): a novel analytical system to investigate uPA–uPAR interaction and to test synthetic uPAR antagonists as potential cancer therapeutics. Biol Chem 383:207–216
Han HK, Amidon GL (2000) Targeted prodrug design to optimize drug delivery. AAPS PharmSci 2:E6
HariKrishna D, Rao AR, Krishna DR (2003) Selective activation of anthracycline prodrugs for use in conjunction with ADEPT. Drug News Perspect 16:309–318
Hiner ANP, Hernández-Ruíz J, Amao MB, García-Cánovas F, Acosta M (1996) A comparative study of the purity, enzyme activity, and inactivation by hydrogen peroxide of commercially available horseradish peroxidase isoenzymes A and C. Biotechnol Bioeng 50:655–662
Hinman RL, Lang J (1965) Peroxidase-catalyzed oxidation of indole-3-acetic acid. Biochemistry 4:144–158
Ho W-J, Yuan C-J, Reiko O (2006) Application of SiO2-poly(dimethylsiloxane) hybrid material in the fabrication of amperometric biosensor. Anal Chim Acta 572:248–252
Hock SC, Ying YM, Wah CL (2011) A review of the current scientific and regulatory status of nanomedicines and the challenges ahead. PDA J Pharm Sci Technol 65:177–195
Huysmans G, Ranquin A, Wyns L, Steyaert J, Van Gelder P (2005) Encapsulation of therapeutic nucleoside hydrolase in functionalised nanocapsules. J Control Release 102:171–179
Karlsson KH (1999) Bone implants—a challenge to materials science. Ann Chir Gynaecol 88:226–235
Kawanabe K, Yamamuro T, Nakamura T, Kotani S (1991) Effects of injecting massive amounts of bioactive ceramics in mice. J Biomed Mater Res 25:117–1128
Kim DS, Jeon SE, Park KC (2004) Oxidation of indole-3-acetic acid by horseradish peroxidase induces apoptosis in G361 human melanoma cells. Cell Signal 16:81–88
Kobayashi S, Sugioka K, Nakano H, Nakano M, Tero-Kubota S (1984) Analysis of the stable end products and intermediates of oxidative decarboxylation of indole-3-acetic acid by horseradish peroxidase. Biochemistry 23:4589–4597
Kratz F, Warnecke A, Schmid B, Chung DE, Gitzel M (2006) Prodrugs of anthracyclines in cancer chemotherapy. Curr Med Chem 13:477–523
Li X, Zhang Y, Yan R, Jia W, Yuan M, Deng X, Huang Z (2000) Influence of process parameters on the protein stability encapsulated in poly-DL-lactide-poly(ethylene glycol) microspheres. J Control Release 68:41–52
Matsoukas T, Gulari E (1988) Dynamics of growth of silica particles from ammonia-catalyzed hydrolysis of tetra-ethyl-orthosilicate. J Colloid Interface Sci 124:252–261
Mauger AB, Burke PJ, Somani HH, Friedlos F, Knox RJ (1994) Self-immolative prodrugs: candidates for antibody-directed enzyme prodrug therapy in conjunction with a nitroreductase enzyme. J Med Chem 37:3452–3458
Nishi Y (2003) Enzyme/abzyme prodrug activation systems: potential use in clinical oncology. Curr Pharm Des 9:2113–2130
Park SK, Kim KD, Kim HT (2002) Preparation of silica nanoparticles: determination of the optimal synthesis conditions for small and uniform particles. Colloids Surf A Physicochem Eng Aspects 197:7–17
Petri-Fink A, Chastellain M, Juillerat-Jeanneret L, Ferrari A, Hofmann H (2005) Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells. Biomaterials 26:2685–2694
Qhobosheane M, Santra S, Zhang P, Tan W (2001) Biochemically functionalized silica nanoparticles. Analyst 126:1274–1278
Rodriguez-López JN, Gilabert MA, Tudela J, Thorneley RN, Garcia-Cánovas F (2000) Reactivity of horseradish peroxidase compound II toward substrates: kinetic evidence for a two-step mechanism. Biochemistry 39:13201–13209
Rudolphi A, Vielhauer S, Boos KS, Seidel D, Bathge IM, Berger H (1995) Coupled-column liquid chromatographic analysis of epirubicin and metabolites in biological material and its application to optimization of liver cancer therapy. J Pharm Biomed Anal 13:615–623
Shchipunov YA, Karpenko TY, Bakunina IY, Burtseva YV, Zvyagintseva TN (2004) A new precursor for the immobilization of enzymes inside sol–gel-derived hybrid silica nanocomposites containing polysaccharides. J Biochem Biophys Methods 58:25–38
Smith AM, Morrison WL, Milham PJ (1982) Oxidation of indole-3-acetic acid by peroxidase: involvement of reduced peroxidase and compound III with superoxide as a product. Biochemistry 21:4414–4419
Syrigos KN, Epenetos AA (1999) Antibody directed enzyme prodrug therapy (ADEPT): a review of the experimental and clinical considerations. Anticancer Res 19:605–613
Van Helden AK, Jansen JW, Vrij A (1981) Preparation and characterization of spherical monodisperse silica dispersions in nonaqueous solvents. J Colloid Interface Sci 81:354–368
Wardman P (2002) Indole-3-acetic acids and horseradish peroxidase: a new prodrug/enzyme combination for targeted cancer therapy. Curr Pharm Res 8:1363–1374
Wu X, Narsimha G (2008) Characterization of secondary and tertiary conformational changes of beta-lactoglobulin adsorbed on silica nanoparticle surfaces. Langmuir 24:4989–4998
Wu S, Lin J, Chan SI (1994) Oxidation of dibenzothiophene catalyzed by heme-containing enzymes encapsulated in sol–gel glass. A new form of biocatalysts. Appl Biochem Biotechnol 47:11–20
Acknowledgments
The authors would like to thank Dr. Hoi-Ping Shi and the laboratory of Dr. Tung-Kung Wu for technical support. The authors would like to thank the ATU plan of Ministry of Education of the R.O.C. (Taiwan) and the National Science Council of the R.O.C. (Taiwan) under Contract No. NSC 97-2311-B-009-001-MY3 for financially supporting this research.
Author information
Authors and Affiliations
Corresponding author
Additional information
Y.-R. Chiu and W.-J. Ho contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Chiu, YR., Ho, WJ., Chao, JS. et al. Enzyme-encapsulated silica nanoparticle for cancer chemotherapy. J Nanopart Res 14, 829 (2012). https://doi.org/10.1007/s11051-012-0829-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11051-012-0829-1